Synthesis, characterization and DNA binding studies of organoantimony(V) ferrocenyl benzoates

[1]  C. Biot,et al.  Ferrocene-based antimalarials. , 2012, Future medicinal chemistry.

[2]  V. Moreno,et al.  New π-arene ruthenium(II) piano-stool complexes with nitrogen ligands. , 2012, Journal of inorganic biochemistry.

[3]  Mei Han,et al.  DNA- and RNA-binding and enhanced DNA-photocleavage properties of a ferrocenyl-containing ruthenium(II) complex. , 2012, Journal of inorganic biochemistry.

[4]  A. Laguna,et al.  Conjugates of ferrocene with biological compounds. Coordination to gold complexes and antitumoral properties. , 2011, Journal of inorganic biochemistry.

[5]  C. Ornelas Application of ferrocene and its derivatives in cancer research , 2011 .

[6]  Ke-Zhi Wang,et al.  The interesting DNA-binding properties of three novel dinuclear Ru(II) complexes with varied lengths of flexible bridges. , 2011, Journal of inorganic biochemistry.

[7]  V. N. Babin,et al.  Antitumor activities of ferrocene compounds , 2010 .

[8]  A. Guadalupe,et al.  Electrochemical and Spectroscopical Characterization of Ferrocenyl Chalcones , 2010 .

[9]  G. Leclercq,et al.  A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines. , 2010, Journal of inorganic biochemistry.

[10]  Afzal Shah,et al.  Voltammetric and spectroscopic investigations of 4-nitrophenylferrocene interacting with DNA. , 2010, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[11]  F. Arjmand,et al.  Synthesis, characterization and DNA-binding studies of mono and heterobimetallic complexes CuSn2/ZnSn2 and their DNA cleavage activity , 2010 .

[12]  Afzal Shah,et al.  Electrochemical behaviour of dimethyl-2-oxoglutarate on glassy carbon electrode. , 2010, Bioelectrochemistry.

[13]  Z. Rehman,et al.  Synthesis, spectroscopic characterization, X-ray structure and evaluation of binding parameters of new triorganotin(IV) dithiocarboxylates with DNA. , 2009, European journal of medicinal chemistry.

[14]  Zia-ur-Rehman,et al.  Synthesis, characterization and DNA binding studies of penta- and hexa-coordinated diorganotin(IV) 4-(4-nitrophenyl)piperazine-1-carbodithioates , 2009 .

[15]  Afzal Shah,et al.  Determination of Binding Parameters and Mode of Ferrocenyl Chalcone­DNA Interaction , 2009 .

[16]  H. Yin,et al.  Synthesis, spectroscopic and structural aspects of triphenylantimony(V) complex with internally functionalized acetylferroceneoxime: Crystal and molecular structures of [C5H5FeC5H4C(CH3)NO]2SbPh3 and C5H5FeC5H4C(CH3)NOH , 2008 .

[17]  A. Cabrera,et al.  Perspectives of antimony compounds in oncology , 2008, Acta Pharmacologica Sinica.

[18]  P. Fedoročko,et al.  Cytotoxic activity of proflavine diureas: synthesis, antitumor, evaluation and DNA binding properties of 1',1''-(acridin-3,6-diyl)-3',3''-dialkyldiureas. , 2008, Bioorganic & medicinal chemistry.

[19]  M. Aslanoglu Electrochemical and Spectroscopic Studies of the Interaction of Proflavine with DNA , 2006, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[20]  L. Ji,et al.  Synthesis, characterization and DNA-binding of novel chiral complexes Δ- and Λ-[Ru(bpy)2L]2+ (L = o-mopip and p-mopip) , 2006 .

[21]  M. Sekine,et al.  Use of ferrocene scaffolds as pendant groups in hairpin-type pyrrole-imidazole polyamide molecules showing sequence-selective binding to DNA duplexes. , 2005, The Journal of organic chemistry.

[22]  Ying Ma,et al.  Interaction of anticancer drug mitoxantrone with DNA analyzed by electrochemical and spectroscopic methods. , 2005, Biophysical chemistry.

[23]  Guo-cang Wang,et al.  Synthesis, characterization and structure of some arylantimony ferrocenylacrylates , 2004 .

[24]  H. Ju,et al.  Supermolecular Interaction of Ferrocenium with Yeast DNA and Application in Electrochemical Sensing for Hybridization Recognition of Yeast DNA , 2004, Sensors (Basel, Switzerland).

[25]  Yongqiang Ma,et al.  Synthesis, characterization and in vitro antitumor activity of some arylantimony ferrocenylcarboxylate derivatives and the crystal structures of [C5H5FeC5H4C(CH3)CHCOO]2Sb(C6H4F-4)3 and [4-(C5H5FeC5H4)C6H4COO]2Sb(C6H4F-4)3 , 2004 .

[26]  J. Hsu,et al.  Inhibition of authentic hepatitis C virus replication by sodium stibogluconate. , 2003, Biochemical and biophysical research communications.

[27]  J. Cui,et al.  Synthesis, characterization and in vitro antitumor activity of some arylantimony ferrocenecarboxylates and crystal structures of C5H5FeC5H4CO2SbPh4 and (C5H5FeC5H4CO2)2Sb(4‐CH3C6H4)3 , 2003 .

[28]  Jun-sheng Yu,et al.  Chlorobenzylidine-herring sperm DNA interaction: binding mode and thermodynamic studies. , 2003, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[29]  E. Borden,et al.  Anticancer Activity of Sodium Stibogluconate in Synergy with IFNs1 , 2002, The Journal of Immunology.

[30]  Ke-Qing Zhao,et al.  4-Ferrocenylbenzoic Acid , 2001 .

[31]  D. Osella,et al.  On the mechanism of the antitumor activity of ferrocenium derivatives , 2000 .

[32]  Y. Wataya,et al.  Synthesis of novel ferrocenyl sugars and their antimalarial activities. , 2000, Bioorganic & medicinal chemistry letters.

[33]  C. Biot,et al.  Synthesis and antifungal activity of a ferrocene-fluconazole analogue. , 2000, Bioorganic & medicinal chemistry letters.

[34]  Jian-hui Jiang,et al.  Voltammetric studies of the interaction of daunomycin anticancer drug with DNA and analytical applications , 1998 .

[35]  Nanqiang Li,et al.  Electrochemical studies of porphyrin interacting with DNA and determination of DNA , 1997 .

[36]  T. W. Welch,et al.  Distribution of Metal Complexes Bound to DNA Determined by Normal Pulse Voltammetry , 1996 .

[37]  N. Turro,et al.  Luminescence Quenching in Supramolecular Systems: A Comparison of DNA- and SDS Micelle-Mediated Photoinduced Electron Transfer between Metal Complexes , 1996 .

[38]  C. Brett,et al.  Electrochemistry: Principles, Methods, and Applications , 1993 .

[39]  J. Besancon,et al.  Synthèe, caractérisation et propriétés cytotoxiques des premiers ‘métallocénonucléosides’ , 1991 .

[40]  Michael T. Carter,et al.  Voltammetric studies of the interaction of metal chelates with DNA. 2. Tris-chelated complexes of cobalt(III) and iron(II) with 1,10-phenanthroline and 2,2'-bipyridine , 1989 .

[41]  A. Wolfe,et al.  Polycyclic aromatic hydrocarbons physically intercalate into duplex regions of denatured DNA. , 1987, Biochemistry.

[42]  D. Crothers,et al.  Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on interaction of daunomycin with deoxyribonucleic acid. , 1982, Biochemistry.

[43]  M. Waring,et al.  Complex formation between ethidium bromide and nucleic acids. , 1965, Journal of molecular biology.

[44]  F. Peter,et al.  Advances in the Therapeutics of Antimony , 1938, The Indian Medical Gazette.

[45]  Małgorzata Komorowska,et al.  Biomedical Engineering: Trends, Research and Technologies , 2014 .

[46]  Afzal Shah,et al.  Electrochemical behavior of 1-ferrocenyl-3-phenyl-2-propen-1-one on glassy carbon electrode and evaluation of its interaction parameters with DNA , 2010 .

[47]  G. Sheldrick A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[48]  P. Štěpnička Ferrocenes : ligands, materials and biomolecules , 2008 .

[49]  Sarman Singh,et al.  Kala-azar-new developments in diagnosis and treatment , 1999, Indian journal of pediatrics.

[50]  A. Vessières,et al.  Ferrocenyl hydroxytamoxifen: a prototype for a new range of oestradiol receptor site-directed cytotoxics , 1996 .

[51]  S. Takenaka,et al.  Metal ion assisted DNA-intercalation of crown ether-linked acridine derivatives , 1990 .

[52]  E. Merian Metal toxicity in mammals: Edited by D. Luckey and B. Venugopal , 1980 .

[53]  R. Menzies,et al.  118. Covalency, co-ordination, and chelation. Part III , 1950 .